Clinical trial · Observational
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
NCT05907681CI-TRIAL-00091577recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Metastatic Breast Cancer | Malignant Breast Neoplasm | CURATED_BROADER | 0.78 |
| Radiation Therapy Complication | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Local control rate
- timeFrame
- 1-year
- description
- LC after radiation therapy
Secondary outcomes (3)
- measure
- Overall survival rate
- timeFrame
- 1-year
- measure
- Disease-free survival
- timeFrame
- 1-year
- description
- disease-free survival rate after the time of RT
- measure
- Treatment-related toxicities
- timeFrame
- 1-year
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 19 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: * histologically confirmed breast cancer * presence of distant metastasis * radiation therapy using IMRT, SBRT, or proton therapy is done or planned * Able and willing to comply with the study protocol Exclusion Criteria: * unable to adhere to the study protocol
References
Publications (0)
Data not yet available
No reference posted for this study.